Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Vues
• 08/09/23
0
0
Intégrer
administrator
Les abonnés
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires